Marc Wilson, CFO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 10,000 shares at $28.75 ($288K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Scheduled sale ($288k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CRNX | SELL | 2024-07-17 | $1.4M | — | Filing → |
| CRNX | SELL | 2024-07-02 | $2.8M | — | Filing → |
| CRNX | SELL | 2024-03-20 | $596K | — | Filing → |